🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Papers
The Tuberculosis Drug Accelerator at year 10: what have we learned?

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Tuberculosis Drug Accelerator at year 10: what have we learned?

Nature Medicine(2021)10.1038/s41591-021-01442-2Source: DataRank Database

The Tuberculosis Drug Accelerator at year 10: what have we learned? is a research paper published in Nature Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (30 grants)Impact (FWCI 2.71)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

FFindable (1/2)

Has DOI

AAccessible (1/2)

Open Access

IInteroperable (0/2)

RReusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (37)

David Barros-Aguirre ORCID,Clifton E. Barry ORCID,Robert H. Bates ORCID,Steven J. Berthel ORCID,Helena I. Boshoff ORCID

Live enrichment

PubMed:34226736 PMC:PMC10478072 OpenAlex:https://openalex.org/W3178023815

Bill and Melinda Gates Foundation

Grant: INV-006688

Bill and Melinda Gates Foundation

Grant: OPP1189457

Bill and Melinda Gates Foundation

Grant: OPP1204444

Bill and Melinda Gates Foundation

Grant: OPP1178195

Bill and Melinda Gates Foundation

Grant: OPP1066878

Bill and Melinda Gates Foundation

Grant: INV-008249

Bill and Melinda Gates Foundation

Grant: INV-009358, OPP1129600

Bill and Melinda Gates Foundation

Grant: n/a

Bill and Melinda Gates Foundation

Grant: INV025337

Bill and Melinda Gates Foundation

Grant: OPP1208899

Bill and Melinda Gates Foundation

Grant: INV-004757

Bill and Melinda Gates Foundation

Grant: INV-019631

Bill and Melinda Gates Foundation

Grant: INV-005585, OPP1024038

Bill and Melinda Gates Foundation

Grant: INV-009105

Bill and Melinda Gates Foundation

Grant: OPP1182859

Bill and Melinda Gates Foundation

Grant: INV-009173

Bill and Melinda Gates Foundation

Grant: OPP1108452

Bill and Melinda Gates Foundation

Grant: INV-002178

Bill and Melinda Gates Foundation

Grant: INV-004761, INV-004764

Bill and Melinda Gates Foundation

Grant: INV-002431

Bill and Melinda Gates Foundation

Grant: OPP1024021

Bill and Melinda Gates Foundation

Grant: INV-004704

Bill and Melinda Gates Foundation

Grant: INV-004709

Bill and Melinda Gates Foundation

Grant: INV-007118, INV-002563

U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health

Grant: U19AI111143

U.S. Department of Health & Human Services | National Institutes of Health

Grant: R01 AI150684-01

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Grant: AI000693-25

Intramural NIH HHS

Grant: Z99 AI999999

National Institutes of Health

Grant: 5R01AI150684-04

Lesion-centric optimization of multidrug therapies for tuberculosis

National Institutes of Health

Grant: 5U19AI111143-04

Tri-Institutional TB Research Unit: Persistence and Latency

FWCI

2.71

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: other-oa

repositoryhttps://discovery.dundee.ac.uk/en/publications/efcc9bd8-2123-4f53-a60f-2e3e183a156b

GREENhttps://discovery.dundee.ac.uk/en/publications/efcc9bd8-2123-4f53-a60f-2e3e183a156b

repositoryhttps://discovery.dundee.ac.uk/en/publications/efcc9bd8-2123-4f53-a60f-2e3e183a156b

publisherhttps://www.nature.com/articles/s41591-021-01442-2.pdf

publisherhttps://www.nature.com/articles/s41591-021-01442-2

Fields of Study

Tuberculosis Research and EpidemiologyHealth and Medical Research ImpactsBiomedical and Engineering EducationMedicine0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Antitubercular AgentsHumansLearningTime FactorsTuberculosisDrug Design

Keywords

TuberculosisDrugMedicineVirologyPharmacologyPathologyIntellectual-property rights/dk/atira/pure/subjectarea/asjc/1300/1300Time FactorsAntitubercular AgentsDrug developmentDrug screeningDrug Designname=General Biochemistry,Genetics and Molecular Biology616Research managementHumansLearningBacterial infection

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

Prevention of tuberculosis in macaques after intravenous BCG immunization

N/A

0.963DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-019-1817-8

Dual RNA-Seq of Mtb-Infected Macrophages In Vivo Reveals Ontologically Distinct Host-Pathogen Interactions

Cell Reports(2020)

co-cited

10.1016/j.celrep.2019.12.033

Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection

N/A

0.845DataRank · unranked

Nature Communications(2020)

co-cited

10.1038/s41467-020-16143-6

Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis

Nature Communications(2020)

co-cited

10.1038/s41467-020-19412-6

Mycobacterium tuberculosis Dissemination Plays a Critical Role in Pathogenesis

N/A

0.809DataRank · unranked

Frontiers in Cellular and Infection Microbiology(2020)

co-cited

10.3389/fcimb.2020.00065

PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis

Science(2020)

co-cited

10.1126/science.aav5912

Mycobacterium tuberculosis Sulfolipid-1 Activates Nociceptive Neurons and Induces Cough

N/A

0.757DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.02.026

Granulocytes act as a niche for Mycobacterium tuberculosis growth

Mucosal Immunology(2020)

co-cited

10.1038/s41385-020-0300-z

Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung

N/A

0.799DataRank · unranked

The Journal of Experimental Medicine(2021)

co-cited

10.1084/jem.20210615

Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice

The Journal of Experimental Medicine(2021)

co-cited

10.1084/jem.20210469